Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants

• Ritsuki Kuramoto ,

  Contributed equally to this work with: Ritsuki Kuramoto, Ryoji Kise, Mayu Kanno

  Roles Conceptualization, Investigation, Writing – original draft

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  ⨯
• Ryoji Kise ,

  Contributed equally to this work with: Ritsuki Kuramoto, Ryoji Kise, Mayu Kanno

  Roles Conceptualization, Methodology, Writing – original draft

  * E-mail: iaska@tohoku.ac.jp (AI); ryoji.kise.d4@tohoku.ac.jp (RK)

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  ⨯
• Mayu Kanno ,

  Contributed equally to this work with: Ritsuki Kuramoto, Ryoji Kise, Mayu Kanno

  Roles Investigation

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  ⨯
• Kouki Kawakami,

  Roles Investigation

  Current address: Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  https://orcid.org/0000-0002-2507-8619

  ⨯
• Tatsuya Ikuta,

  Roles Investigation

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  https://orcid.org/0000-0002-8597-0609

  ⨯
• Noriko Makita,

  Roles Resources

  Affiliation Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Asuka Inoue

  Roles Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft

  * E-mail: iaska@tohoku.ac.jp (AI); ryoji.kise.d4@tohoku.ac.jp (RK)

  Affiliation Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan

  https://orcid.org/0000-0003-0805-4049

  ⨯